Jubilant Pharmova Limited — JV/Acquisition, 30-12-2025: Acquisition

Jubilant Pharmova, via its subsidiary, has made an initial investment of CAD 30,000 (INR 0.20 Cr) in Jubilant Pharmaceuticals Inc., Canada. This strategic move establishes the Canadian entity as a new, wholly-owned subsidiary. The core rationale is to build a branded generic business, significantly strengthening Jubilant's market presence in Canada and laying the groundwork for future revenue growth in the pharmaceutical sector. This marks a clear push into new geographic markets.